• Launch of the TMR sensor project for industrial applications
• Miniaturized Biochip gFET design by 97% to reduce cost and improve foundry readiness
• Moved closer to feasibility stages and improved testing accuracy for the Biochip's detection of chronic kidney disease
• Improved control and readout of the 12CQ quantum project

Archer Materials Limited, a semiconductor company advancing the quantum computing and medical diagnostics industries, provided its Quarterly Activities Report and Appendix 4C for the quarter ended 31 December 2024. The company reported progress across its key technology development areas. In quantum technologies, the 12CQ project saw advancements in readout and control, with the development of a new device architecture that achieved the 'Coulomb Blockade' phenomenon at room temperature, helping move the research forward in terms of control and room temperature functionality. The company also extended the spin coherence lifetimes of its carbon nanosphere material and novel manufacturable carbon films, while bolstering the films' sample-to-sample reproducibility. Archer also announced the launch of a new technology vertical in quantum-based TMR sensors, leveraging its expertise in quantum mechanics to develop specialised sensors for industrial applications, which is expected to open a new market and potentially provide an earlier revenue stream. In the Biochip medical diagnostics project, the company achieved significant milestones, including miniaturizing the graphene field effect transistor (gFET) design by 97% to reduce cost and improve foundry readiness, while also moving closer to feasibility stages and improving testing accuracy for the detection of chronic kidney disease. Archer maintained a strong cash position of $16.8 million at the end of the quarter, supported by a $2.1 million cash rebate from the Australian Government's R&D Tax Incentive program.

Archer has a solid runway to bring its quantum computing, medical diagnostics, and TMR sensor technologies to market, with the people and balance sheet in place to support the growth.